J. Brownlees et al., TAU-PHOSPHORYLATION IN TRANSGENIC MICE EXPRESSING GLYCOGEN-SYNTHASE KINASE-3-BETA TRANSGENES, NeuroReport, 8(15), 1997, pp. 3251-3255
IN order to investigate the effect on tau of manipulating glycogen syn
thase kinase (GSK)-3 beta activity in the brain, we created transgenic
mice harbouring wild-type GSK-3 beta genes or a mutant GSK-3 beta tha
t is predicted to be more active. Transgene-derived mRNAs were detecte
d in the brains of a number of the transgenic mouse lines and several
of these transgenic lines displayed transgenic GSK-3 beta activity. We
stern blot analyses of the two lines with the highest levels of transg
enic GSK-3 beta activity revealed that the phosphorylation status of t
au was elevated at the AT8 epitope. These observations strongly sugges
t that GSK-3 beta is an in vivo tau kinase in the brain. Only low leve
ls of expression of GSK-3 beta were obtained and it is possible that h
igh levels of GSK-3 beta activity are lethal.